C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma

C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma

Purpose: We evaluated the clinical importance, such as the occurrence of postoperative pancreatic fistula (POPF) or prognosis, of preoperative serum markers of chronic inflammation, nutrition, and immunity, as well as that of serum tumor markers after curative resection of pancreatic ductal adenocar...

Full description

Bibliographic Details
Main Authors:	Masahide Ikeguchi, Takehiko Hanaki, Kanenori Endo, Kazunori Suzuki, Seiichi Nakamura, Takashi Sawata, Tetsu Shimizu
Format:	Article
Language:	English
Published:	Mary Ann Liebert 2017-07-01
Series:	Journal of Pancreatic Cancer
Subjects:	C-reactive protein/albumin ratio overall survival pancreatic ductal adenocarcinoma postoperative pancreatic fistula prognostic nutritional index
Online Access:	https://www.liebertpub.com/doi/full/10.1089/PANCAN.2017.0006

Similar Items

Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis
by: Ke Zhang, et al.
Published: (2020-06-01)

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
by: Wenjing Song, et al.
Published: (2021-06-01)

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
by: Liao X, et al.
Published: (2017-09-01)

Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study
by: Jun-Chao Guo, et al.
Published: (2020-05-01)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma
by: Hu SP, et al.
Published: (2020-01-01)

The ultimate preoperative C-reactive protein-to-albumin ratio is a prognostic factor for survival after pancreatic cancer resection
by: Laura van Wijk, et al.
Published: (2020-10-01)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
by: Haoda Chen, et al.
Published: (2021-06-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms
by: Jun-Qi Liu, et al.
Published: (2020-12-01)

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
by: Meng Guo, et al.
Published: (2016-07-01)

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
by: Byeong Geun Song, et al.
Published: (2021-02-01)

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
by: Dimitrios Giannis, et al.
Published: (2021-03-01)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

Three-year and five-year outcomes of surgical resection for pancreatic ductal adenocarcinoma: Long-term experiences in one medical center
by: Chih-Po Hsu, et al.
Published: (2018-03-01)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
by: Wen-Jing Liu, et al.
Published: (2018-01-01)

A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications
by: Zengyu Feng, et al.
Published: (2021-03-01)

Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model
by: Ching-Fu Chang, et al.
Published: (2019-01-01)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
by: Yusheng Shi, et al.
Published: (2021-01-01)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
by: Bathiya Ratnayake, et al.
Published: (2020-07-01)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
by: Dongjie Chen, et al.
Published: (2021-10-01)

Pathomorphological characteristics of the restructuring of pancreatic ductal system in chronic pancreatitis
by: Kovalenko I.S.
Published: (2013-01-01)

Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma
by: Ge Li, et al.
Published: (2020-05-01)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
by: Christelle d’Engremont, et al.
Published: (2021-05-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
by: He Xu, et al.
Published: (2021-02-01)

Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma
by: Azaz Ahmed, et al.
Published: (2021-01-01)

The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma
by: Li S, et al.
Published: (2019-04-01)

Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas
by: Sho Fujiwara, et al.
Published: (2019-04-01)

Prognostic value of the creatinine-albumin ratio in acute pancreatitis debridement
by: Zhifeng Zhao, et al.
Published: (2020-12-01)

Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma
by: J. Zhao, et al.
Published: (2016-07-01)

An excerpt of international consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
by: QI Bing, et al.
Published: (2018-03-01)

Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
by: Hong-Bin Li, et al.
Published: (2021-09-01)

A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-09-01)

Prognostic significance of EIF4G1 in patients with pancreatic ductal adenocarcinoma
by: Goh TS, et al.
Published: (2019-04-01)

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

Phosphomannose Isomerase High Expression Associated with Better Prognosis in Pancreatic Ductal Adenocarcinoma
by: Alipour Z, et al.
Published: (2021-09-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

Cannot write session to /tmp/vufind_sessions/sess_1gs94688s10l08f903gpdm7k8s